India · English
Lupin launches fixed-dose triple-combination inhaler for COPD in India
Formoflo-G MDI combines three established therapies in a twice-daily inhaler after DCGI approval, targeting India's large COPD patient pool
Read the full report at Business Standard →
How 2 newsrooms ran it
2 of our sources carried this story over 1.9 hours. Business Standard filed first, at 11:30 IST. The headlines below are each outlet's own wording, in the order they published.
| Time IST | Outlet | Their headline |
|---|---|---|
| 11:30 | Business Standard | Lupin launches fixed-dose triple-combination inhaler for COPD in India |
| 13:25 | The Hindu BusinessLine | Lupin launches fixed-dose triple combination inhaler for COPD in India |
About this page
AKHBAARI groups the same story across publishers so you can see who is reporting it and how they differ. The summary above is machine-generated from the publisher's own feed text and is labelled as such. The full report stays with the publisher, who holds copyright in it. See our editorial policy.